Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Akebia Therapeutics
company
About
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
- 251 - 500
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $41M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$63M
Akebia Therapeutics has raised a total of
$63M
in funding over 2 rounds. Their latest funding was raised on
Jun 4, 2013 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 4, 2013 | Series C | $41M | 1 | — | — | Detail |
| Apr 26, 2011 | Series B | $22M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Akebia Therapeutics has made 2 investments. Their most recent investment was on
Feb 12, 2020, when Arize AI raised $4.02M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 12, 2020
Arize AI
|
Series Unknown | $4.02M | Artificial Intelligence | — |
|
Jan 20, 2020
LatchBio
|
Pre-seed | $200K | Artificial Intelligence | — |
Investors
Number of Lead Investors
Number of Investors
—
1
Akebia Therapeutics is funded by 1 investors.
AgeChem Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
AgeChem Venture Fund
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
